NCT05233592View on ClinicalTrials.gov

Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

March 8, 2022

Primary Completion Date

April 4, 2023

Study Completion Date

April 4, 2023

Conditions
Type 1 DiabetesDiabetes Mellitus, Type 1
Interventions
DEVICE

CGM

Patients wear a CGM to measure the effects of the COVID-19 booster vaccine on blood sugar levels.

Trial Locations (1)

21044

Cardiovascular Specialists of Central Maryland, Columbia

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

Johns Hopkins University

OTHER